Covaxin shows 77.8% efficacy against symptomatic Covid: Lancet

New Delhi, Nov 12: Covaxin, India’s indigenous COVID-19 vaccine by Bharat Biotech demonstrates 77.8% efficacy against symptomatic Covid-19. The trial results have been published in the British medical journal The Lancet after being peer-reviewed. The vaccine is developed using

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News